Estimating the costs attributable to smoking is helpful for evaluating appropriate tax policy, informing both public and private managers of health care, and evaluating alternative smoking cessation programs.
While the smoking-attributable costs ofchronic conditions have been well studied, these costs are less relevant to health maintenance organizations (HMOs) and employers whose populations are younger and transient.
Costs incurred in the short run, such as those related to smoking during pregnancy and environmental tobacco smoke exposure (ETS) of children, are more relevant.
In this article, the authors review studies of these sources of smoking-attributable costs as well as studies that focus on smoking-attributable outcomes and costs from the employer or HMO perspective.
Subsidies may be necessary to induce employers to recognize the full social benefits ofsmoking cessation programs.
Mots-clés Pascal : Tabagisme, Analyse coût, Mère pathologie, Gestation, Gestation pathologie, Nouveau né pathologie, Enfant, Homme, Tabagisme passif, Impact économique, Politique sanitaire, Assurance maladie, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Tobacco smoking, Cost analysis, Maternal diseases, Pregnancy, Pregnancy disorders, Newborn diseases, Child, Human, Passive smoking, Economic impact, Health policy, Health insurance, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0163807
Code Inist : 002B30A01C. Création : 16/11/1999.